Stockscreener 앱 받기
10.82
0.74%
0.08
시간 외 거래:
10.82
전일 마감가:
$10.74
열려 있는:
$10.7
하루 거래량:
787.70K
Relative Volume:
1.60
시가총액:
$500.36M
수익:
$681.50M
순이익/손실:
$15.70M
주가수익비율:
31.82
EPS:
0.34
순현금흐름:
$36.60M
1주 성능:
-1.46%
1개월 성능:
-12.25%
6개월 성능:
-34.46%
1년 성능:
-53.00%
1일 변동 폭
$10.60
$10.84
1주일 범위
$9.303
$11.38
52주 변동 폭
$9.303
$25.36
Avanos Medical Inc Stock (AVNS) Company Profile
명칭
Avanos Medical Inc
전화
844-428-2667
주소
5405 WINDWARD PARKWAY, ALPHARETTA, GA
AVNS을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
AVNS
Avanos Medical Inc
|
10.82 | 479.34M | 681.50M | 15.70M | 36.60M | 0.34 |
|
ABT
Abbott Laboratories
|
134.28 | 227.88B | 43.11B | 13.98B | 6.78B | 7.98 |
|
BSX
Boston Scientific Corp
|
103.14 | 152.55B | 18.49B | 2.51B | 3.23B | 1.68 |
|
SYK
Stryker Corp
|
377.58 | 143.34B | 23.82B | 2.92B | 4.02B | 7.55 |
|
MDT
Medtronic Plc
|
92.88 | 114.49B | 33.54B | 4.66B | 5.19B | 3.62 |
|
EW
Edwards Lifesciences Corp
|
78.35 | 46.11B | 5.69B | 4.14B | 577.90M | 6.96 |
Avanos Medical Inc Stock (AVNS) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2023-07-25 | 다운그레이드 | KeyBanc Capital Markets | Overweight → Sector Weight |
| 2023-05-22 | 개시 | CL King | Buy |
| 2021-08-04 | 다운그레이드 | Stephens | Overweight → Equal-Weight |
| 2020-04-13 | 업그레이드 | Barclays | Underweight → Equal Weight |
| 2019-11-07 | 다운그레이드 | Stifel | Buy → Hold |
| 2019-11-06 | 다운그레이드 | Raymond James | Outperform → Mkt Perform |
| 2018-10-16 | 개시 | Barclays | Equal Weight |
| 2018-08-21 | 업그레이드 | Raymond James | Mkt Perform → Outperform |
모두보기
Avanos Medical Inc 주식(AVNS)의 최신 뉴스
Is Avanos Medical Inc. stock a good dividend stockFree Buy and Hold Suggestions - mustnews.co.kr
Should I buy Avanos Medical Inc. stock nowReturn-Optimized Stock Portfolio - kangso.co.kr
Avanos Medical’s Earnings Call: Strategic Growth Amid Challenges - TipRanks
Avanos Medical, Inc. (NYSE:AVNS) Q2 2025 Earnings Call Transcript - MSN
Avanos Medical 2025 Q2 Earnings Sharp Net Loss Amid Revenue Growth - AInvest
Avanos Medical Stock Down as Q2 Earnings Miss Estimates, Margins Down - Yahoo Finance
Avanos maintains $665M–$685M revenue target amid HA divestiture and tariff impact - MSN
Disposable Pain Pumps Market Set to Witness Significant Growth - openPR.com
Avanos Medical Second Quarter 2025 Earnings: US$1.66 loss per share (vs US$0.094 profit in 2Q 2024) - Yahoo Finance
Avanos Medical net loss hits USD 76.8M in Q2 2025 - Medical Buyer
Avanos Medical, Inc.'s (NYSE:AVNS) Revenues Are Not Doing Enough For Some Investors - simplywall.st
Avanos Medical: Q2 Earnings Snapshot - New Haven Register
Avanos Medical Inc (AVNS) Q2 2025 Earnings Call Highlights: Strong Sales Growth Amid Strategic ... By GuruFocus - Investing.com Canada
Avanos Medical Inc (AVNS) Q2 2025 Earnings Call Highlights: Stro - GuruFocus
Avanos Medical Reports Q2 2025 Financial Results - TipRanks
Avanos Medical, Inc. 2025 Q2ResultsEarnings Call Presentation (NYSE:AVNS) - Seeking Alpha
Earnings call transcript: Avanos Medical beats Q2 2025 earnings, stock tumbles - Investing.com
Avanos (AVNS) Q2 2025 Earnings Call Transcript - AOL.com
Avanos Q2 2025 slides: Revenue grows while profits decline, shares tumble - Investing.com Canada
Avanos (AVNS) Q2 2025 Earnings Call Transcript - The Motley Fool
Avanos Medical Inc reports results for the quarter ended June 30Earnings Summary - TradingView
Avanos Medical (AVNS) Misses Q2 Earnings Estimates - sharewise.com
Avanos Medical Appoints New CFO Amid Financial Challenges - TipRanks
Avanos Medical, Inc. Announces Second Quarter 2025 Results | AVNS Stock News - GuruFocus
Avanos Medical Q2 net sales rise 1.9%, beat expectations - MarketScreener
AVNS names new CFO, divests HA line; CEO joins board in 8-K filing | AVNS SEC FilingForm 8-K - Stock Titan
Avanos Medical Announces Appointment of Scott Galovan as Senior Vice President, Chief Financial Officer; David Pacitti Appointed to Board of Directors - WV News
Avanos Medical earnings beat by $0.02, revenue topped estimates - Investing.com Canada
Avanos Medical, Inc. Announces Second Quarter 2025 Results - PR Newswire
Should I hold or sell Avanos Medical Inc. stock in 2025Overwhelming profit margins - Jammu Links News
Avanos Medical Inc. Stock Analysis and ForecastInvest smarter and grow your wealth faster - Jammu Links News
How many analysts rate Avanos Medical Inc. as a “Buy”Invest smarter with daily stock recommendations - Jammu Links News
Is Avanos Medical Inc. a good long term investmentHigh-performance stocks for savvy investors - Jammu Links News
What are the latest earnings results for Avanos Medical Inc.Skyrocketing returns - Jammu Links News
What are analysts’ price targets for Avanos Medical Inc. in the next 12 monthsAccelerated investment success - Jammu Links News
Why is Avanos Medical Inc. stock attracting strong analyst attentionHigh-performance investment picks - Jammu Links News
What catalysts could drive Avanos Medical Inc. stock higher in 2025Gain insights from top financial experts - Jammu Links News
How strong is Avanos Medical Inc. company’s balance sheetDynamic profit expansion - Jammu Links News
What are Avanos Medical Inc. company’s key revenue driversCapitalize on emerging growth stocks - Jammu Links News
What makes Avanos Medical Inc. stock price move sharplyUnlock your portfolio’s full growth potential - Jammu Links News
Does Avanos Medical Inc. stock perform well during market downturnsStock Market Picks With High Returns - jammulinksnews.com
Is it the right time to buy Avanos Medical Inc. stockEntry Signal Tracker With Proven Results - Jammu Links News
Avanos Announces Divestiture of Hyaluronic Acid Product Line to Channel-Markers Medical | AVNS Stock News - GuruFocus
Avanos Divests Popular Knee Pain Products TriVisc and GenVisc in Strategic Portfolio Shift - Stock Titan
Avanos Medical Inc (AVNS) 재무 분석
매출
순이익
현금흐름
주당 순 이익
1.17%
자본화:
|
볼륨(24시간):